Lucite tombstone marking equity financing of Minneapolis-based CVRx, a medical device maker.The company produces an implantable device to treat high blood pressure and heart failure.
(6ADL737)Lucite tombstone marking equity financing of Minneapolis-based CVRx, a medical device maker.The company produces an implantable device to treat high blood pressure and heart failure.
(6ADL737)Lucite tombstone marking the acquisition of Blockade Medical by Balt International. Blockade develops endovascular, catheter-based devices for the treatment of cerebral aneurysms.
(6ALJC03)Custom Lucite with embedded pills marking the acquisition by Peruvian pharmacy operator Mifarma of Albis Capital. (6AGP86)
Lucite deal toy commemorating the sale by Advent International of its stake in CARE Hospitals, based in Hyderabad, India.
(6LACA37)Back view of pill-themed financial tombstone marking the purchase of New Zealand Pharmaceuticals (NZD). The acquirer was Australian private equity firm Archer Capital.
(6ALR257)Fitness-themed Lucite tombstone marking the acquisition of Cybex International, a manufacturer of commercial fitness equipment, including cardiovascular and strength products. Cybex is based in Medway, Massachusetts.
(6ADL583)Pill-themed deal toy marking related pharmaceutical and healthcare transactions involving McKesson and Celesio.
(6LACC85)Pill/tablet themed deal toy marking the sale by Bayer Korea of the drug Mercilon.
(6LACB53)Lucite commemorative marking a research and development joint venture between Massachusetts-based CRISPR, and German drug company Bayer. The collaboration will center on CRISPR’s gene-editing technology, and focus on the treatment of conditions such as congenital heart disease, blood disorders, and blindness.
(6AGP903)